The findings from the final section (part iii) of the CPhI Annual Report have been announced by event organisers UBM.
Microphones
This section, which focused on the immediate and long-term trends in pharmaceutical data, regulation, generics and biosimilars, included a warning that the six sigma adoption is slowing as a result of regulatory oversight, and has forecasted an increase in generic options from 2025.